03
October 2018, The global eClinical Solutions Market is anticipated
to exceed USD 13 billion by 2024. The major growth driving factors include a
rise in the R&D activities by various pharma and biopharma companies,
growing application of software solutions in medical trials, rising government
funding for promoting clinical research programs, increasing consumer base, and
so on. In addition to this, rising outsourcing of medical trials to Contract
Research Organization (CROs), growing medical research programs in various
Asian countries along with the development of low-cost modules are also
projected to boost the market growth.
However,
high implementation prices, the lack of skilled labor & awareness about
clinical data sciences software are likely to hinder the growth of the market
in the near future. The global market is divided into products and regions.
Browse Details of Report @ https://www.hexaresearch.com/research-report/eclinical-solutions-market
The
products sector includes Electronic Data Capture (EDC), Electronic Clinical
Outcome Assessment (ECOA), Clinical Data Management Systems (CDMS),
Randomization and Trial Supply Management (RTSM), Safety Solutions, Clinical
Data Integration Platforms, Clinical Trial Management Systems (CTMS), and
Electronic Trial Master File (e-TMF). The ECOA sector is projected to
experience the maximum growth rate over the forecast period (from 2016 to
2024), while the CDMS and EDC sectors are anticipated to dominate the market
through the year 2016.
Regionally,
the global eClinical solutions market is segregated as Latin America, North
America, Asia-Pacific, Europe, and the Middle East & Africa. As of 2016,
the North American market is expected to dominate the global market occupying
the largest industry share. The major factor for this growth is the growing number
of ongoing medical trials in the region. Some other factors include the rising
government support for clinical trials, extensive Research & Development
activities resulting in the production and launch of innovative products, and
the increasing occurrences of lifestyle diseases. The APAC region is also
likely to witness a rapid growth over the next few years. The rising
participation of developing countries in the clinical trials is said to augment
the market growth during the estimated years.
The
key companies operating in the global eClinical solutions market are Parexel
International Corp.; ERT inc.; Oracle Corp.; BioClinica; DataTrak International
Inc.; Medidata Solution Inc.; Merge Health Inc.; CRF Health Inc.; OmniComm
Systems Inc.; and eClinical Solutions LLC.
No comments:
Post a Comment